Please see the important notice at the end of this announcement.
The prospectus relating to Alimak Group AB's (publ) ("Alimak") rights issue of approximately SEK 791 million has been approved and registered by the Swedish Financial Supervisory Authority and is now available on the company's website http://www.alimakgroup.com. The prospectus and a pre-printed issue statement will be sent by mail to Alimak's directly registered shareholders in Sweden.
The prospectus and application forms for subscription without preferential right can be obtained from Alimak and Handelsbanken. The prospectus and application forms for subscription without preferential right will also be available on Alimak's website http://www.alimakgroup.com and on Handelsbanken's website www.handelsbanken.se/ investeringserbjudande (only in Swedish).
Handelsbanken Capital Markets is acting as financial advisor and Hannes Snellman Attorneys is acting as legal advisor to Alimak in relation to the rights issue.
For further information, contact:
Per Ekstedt, CFO, Phone +46 8 402 14 57
Sofia Wretman, Head of Communications & IR, Phone: +46 8 402 14 41
The information was submitted for publication at 13.00 CET on 13 March 2017.
About Alimak Group
Alimak Group is a world-leading provider of vertical access solutions for industrial and construction industries. With presence in more than 100 countries, Alimak develops, manufactures, sells and provides service to vertical access solutions with focus on adding customer value through greater safety, higher productivity and improved cost efficiency. The Group's products and solutions are sold under the brands Alimak Hek, CoxGomyl, Manntech and Avanti. Alimak has an installed base of more than 60,000 elevators, hoists, platforms, service lifts and building maintenance units around the world. Founded in Sweden 1948 Alimak has its headquarters in Stockholm, 12 manufacturing facilities in 8 countries and 2,400 employees around the world. www.alimakgroup.com
The information in this press release does not contain or constitute an offer to acquire, subscribe or otherwise trade in shares, subscription rights or other securities in Alimak. Any invitation to the persons concerned to subscribe for shares in Alimak will only be made through the prospectus which Alimak publishes on 13 March 2017.
This press release may not be released, published or distributed, directly or indirectly, in or into Australia, Japan, Canada, the United States or any other jurisdiction where participation would require additional prospectuses, registration or measures besides those required by Swedish law. Nor may this press release be distributed in or into such countries or any other country or jurisdiction in which distribution requires such measures or otherwise would be in conflict with applicable regulations. Any failure to comply with the restrictions described may result in a violation of applicable securities regulations.
The subscription rights, paid subscribed shares and shares in Alimak have not been and will not be registered under the United States Securities Act of 1933, as amended (the "Securities Act") or the securities legislation of any state or other jurisdiction in the United States and no subscription rights, paid subscribed shares or shares may be offered, subscribed for, exercised, pledged, sold, resold, granted, delivered or otherwise transferred, directly or indirectly, in or into the United States except pursuant to an applicable exemption from, or in a transaction not subject to, the registration requirements under the Securities Act and in compliance with the securities legislation in the relevant state or any other jurisdiction of the United States. There will be no public offering of such securities in the United States.
The securities referred to herein have not been approved or disapproved by the US Securities and Exchange Commission, any state securities commission or other regulatory authority in the United States, nor have any of the foregoing authorities passed upon or endorsed the merits of the rights issue or the accuracy or adequacy of this announcement. Any representation to the contrary is a criminal offence in the United States.
This press release contains certain forward-looking information that reflects Alimak's present view of future events as well as financial and operational development. Words such as "intend", "assess", "expect", "may", "plan", "believe", "estimate" and other expressions entailing indications or predictions of future development or trends, not based on historical facts, constitute forward-looking information. Forward-looking information is inherently associated with both known and unknown risks and uncertainties as it depends on future events and circumstances. Forward-looking information is not a guarantee of future results or development and actual outcomes may differ materially from the statements set forth in the forward-looking information.